People · Operator
Named in public records as an officer, director or promoter · active 2012–2017 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cambridge Endoscopic Devices Inc | — | Biotechnology | Seed | $12.0M | $129.8M | 2012 |
| Hydrocision Inc | — | Biotechnology | Seed | $9.2M | $10.0M | 2017 |
HOWARD DONNELLY at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside HOWARD DONNELLY on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Marc Goldberg | 1 | 9 |
| Walter Winshall | 1 | 6 |
| Dennis Costello | 1 | 6 |
| Jeff Barnes | 1 | 4 |
| MARC E. GOLDBERG | 1 | 4 |
| Doug Wall | 1 | 4 |
| Glen Kashuba | 1 | 3 |
| John C Miller | 1 | 3 |
| Jeffrey T Barnes | 1 | 3 |
| Terry Wall | 1 | 3 |
| John Schulte | 1 | 3 |
| Thomas D. Abert | 1 | 3 |
| James Lousararian | 1 | 3 |
| Omar Amirana | 1 | 2 |
| Richard J Lim | 1 | 2 |
| DOUG E. WALL | 1 | 1 |
| TERRY E. WALL | 1 | 1 |
| LONG E. ZHAN | 1 | 1 |
| BRYAN E. GRULKE | 1 | 1 |
| HOWARD W. DONNELLY | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.